Screener
Quest Diagnostics DGX EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Quest Diagnostics’s reported figures.
Based on the most recent quarter.
The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001022079-26-000070
FAQ
- What is Quest Diagnostics's EV / EBITDA?
- Quest Diagnostics (DGX) reported EV / EBITDA of 13.2× in Q2 2026.
- How has Quest Diagnostics's EV / EBITDA changed year-over-year?
- Quest Diagnostics's EV / EBITDA increased by 2.0% year-over-year, from 13× to 13.2×.
- What is the long-term trend for Quest Diagnostics's EV / EBITDA?
- Over 5 years (2020 to 2025), Quest Diagnostics's EV / EBITDA has grown at a 8.9% compound annual growth rate (CAGR), from 7.8× to 11.9×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about Quest Diagnostics's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude